Therapeutic Glaucoma

Basil Williams, Jr., MD, reports on the association between development of elevated intraocular pressure and numerous commonly performed vitreoretinal treatments.

Although minimally invasive procedure gives hope, additional research is required.

Pressure-dependent optic nerve disease, retinal disease.

Two trials examine factors affecting the risk of disease.

MIGS drainage device offers hope for challenging cases.

Exploring subtleties helps ophthalmologists understand postop surprises, drug reactions.

Measurements from multiple studies show benefits of rho-kinase inhibition.

Visible-light optical coherence tomography proves valuable in studies.

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.

Option could prove to enhance safety for both patients and staff.

Use of such procedures increased markedly in analysis of IRIS Registry Data.

Virtual reality, home visual field testing offer new options for physicians.

Ophthalmologist details his preferred technique to avoid complications during procedure.

Short learning curve, significant clinical advantages make this a comfortable addition.

IOP-controlling protein in the trabecular meshwork may get the fluid moving.

Investigators find treatment is an option for treating open-angle glaucoma.

A supraciliary minimally invasive glaucoma procedure may offer a valuable bleb-free treatment option for patients with glaucoma that requires low target pressures.

Physician presents pearls for effective use, leading to positive outcomes for patients.

In this latest EyePod® episode, Sahar Bedrood, MD, PhD, shares her clinical perspective on the multi-faceted, dynamic evolution of interventional glaucoma.

Patients show impressive proptosis and diplopia responses to teprotumumab.

Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.

Drops can simplify dosing, improving adherence and ocular surface health

Intraocular drainage surgery may have a future for treating issues.

Consider ideas about outflow pathways, neuroprotection.

Once-daily corticosteroid treats pain, inflammation after surgery.